An update of predictive biomarkers related to WEE1 inhibition in cancer therapy.

Authors:
Wang Z; Li W; Li F; Xiao R.

Journal:
J Cancer Res Clin Oncol

Publication Year: 2024

DOI:
10.1007/s00432-023-05527-y

PMCID:
PMC10794259

PMID:
38231277

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Cancer Res Clin Oncol

Abbreviation: J Cancer Res Clin Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Advances in the antitumor mechanisms of tripartite motif-containing protein 3.
Teng W; Ling Y; Liu Z and 6 more (2024) - Transparency Score: 3/6
A novel EIF3C-related CD8<sup>+</sup> T-cell signature in predicting prognosis and immunotherapy re…
Li R; Wang Y; Wen X and 10 more (2024) - Transparency Score: 4/6
Approved immune checkpoint inhibitors in hepatocellular carcinoma: a large-scale meta-analysis and …
Zhang R; Wang F; You Z and 6 more (2024) - Transparency Score: 3/6
A rare Ewing-like small round cell tumor in prostate: a case report and literature review.
Wang Z; Ye J; Hu J and 2 more (2024) - Transparency Score: 3/6
A retrospective study on the mechanism underlying quick transfer from response to resistance in a r…
Zhong N; Yu D; Yang M and 8 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestThe authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Ethical statementNot applicable. Conflict of interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"Funding This study has received support from the National Natural Science Foundation of China (82060472, 82303671), and the Fundamental Research Funds for the Central Universities (2042023kf0084)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025